1981
DOI: 10.1002/1097-0142(19810401)47:7<1891::aid-cncr2820470730>3.0.co;2-k
|View full text |Cite
|
Sign up to set email alerts
|

Anorectal melanoma

Abstract: Primary malignant melanoma of the anorectum is a rare and virulent malignancy associated with an extremely poor prognosis in spite of aggressive initial therapy. Fifty-one patients with this disease were treated at Memorial Sloan-Kettering Cancer Center during the last 50 years and only six (12%) survived five years. This report views in detail 36 of the patients treated since 1950. In this group there was a female predominance (21 females, 15 males), and median age was in the 6th decade (range 27-75). Common … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
104
0
9

Year Published

1988
1988
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 210 publications
(115 citation statements)
references
References 20 publications
2
104
0
9
Order By: Relevance
“…Anorectal melanoma is a rare form of melanoma that constitutes only 0.4 -1.6% of all melanoma manifestations (Wanebo et al, 1981). It accounts only for approximately 0.5% of all colorectal and anal cancers (Roumen, 1996).…”
mentioning
confidence: 99%
“…Anorectal melanoma is a rare form of melanoma that constitutes only 0.4 -1.6% of all melanoma manifestations (Wanebo et al, 1981). It accounts only for approximately 0.5% of all colorectal and anal cancers (Roumen, 1996).…”
mentioning
confidence: 99%
“…A number of studies claim that an abdomino-perineal resection (APR) is the treatment of choice [7,8] . This is based on the hypothesis that the disease spreads proximally via the submucosa to the mesenteric lymph nodes.…”
Section: Discussionmentioning
confidence: 99%
“…After a brief course of single-agent carboplatin, the patient succumbed to her illness. Anorectal melanoma is rare and accounts for 0.4%-1.6% of all melanoma cases [101] (Figure 4). In one large series, anorectal melanomas represented 0.5% of all colorectal and anal cancers [102].…”
Section: Case Vignettementioning
confidence: 99%
“…Palliative surgery (such as local segmental resection or a diverting colostomy for bowel obstruction) along with systemic therapy is generally advocated for patients with advanced disease (large primary tumors or distant metastases). The presence of metastatic disease has been reported in 20%-62% of patients at the time of initial diagnosis and the prognosis in general for anorectal melanoma is poor, with a 5-year survival rate of about 20% from several studies [101][102][103][104][105][106][107][108].…”
Section: Case Vignettementioning
confidence: 99%